Therapy for acute and chronic hepatitis

Area of Science:

• Hepatology
• Immunology
• Virology

Background:

• Acute and chronic hepatitis present significant therapeutic challenges.
• Current management strategies for severe hepatitis are primarily supportive.

Purpose of the Study:

• To review the current therapeutic landscape for acute and chronic hepatitis.
• To evaluate the efficacy of existing and novel treatment modalities.
• To identify areas for future research in hepatitis management.

Main Methods:

• Comprehensive literature review of hepatitis therapy studies.
• Analysis of clinical trial data for various treatment interventions.
• Assessment of emerging therapeutic agents and approaches.

Main Results:

• No medications are effective for acute, severe acute, or fulminant hepatitis.
• Steroid therapy is effective only in HBsAG-negative chronic active hepatitis with severe lesions.
• Antiviral chemotherapy (interferon, vidarabine) shows potential for chronic hepatitis B, requiring further definition.
• Transfer factor and levamisole demonstrate limited therapeutic promise.

Conclusions:

• Objective evaluation through randomized controlled trials is critical.
• Future hepatitis therapies will likely emerge from a deeper understanding of immunopathogenesis.
• Personalized treatment approaches based on hepatitis type and patient characteristics are essential.